In line with demonstrated Ag cross-presenting ability and unique cell surface repertoire expressed by CD206+ macrophages, increased frequency of CD11b+F4/80hiCD206hi TAM was associated with enhanced Ag-specific CD8+ T cell activation and with concurrently reduced tumor burden in B16-F10 and CT26 syngeneic tumor models. The gene discussed is MRC1; the disease is neoplasm.